On May 22, 2025, leading investment firm HC Wainwright & Co., through their analyst Robert Burns, reaffirmed their "Buy" rating on BioNTech (BNTX, Financial). The firm maintained the price target for the stock at $134.00 USD, showing confidence in the company's ongoing performance and potential growth opportunities.
The maintained rating and price target indicate stability in the analyst's outlook on BioNTech (BNTX, Financial), as there are no changes in the projected valuation of the stock from the prior assessment. The analysis reflects consistent expectations for the company's market performance.
This reaffirmation follows HC Wainwright & Co.'s prior ratings where the "Buy" stance and the $134.00 USD price target were also established. Investors may consider this latest report when evaluating the potential value and investment strategies concerning BioNTech (BNTX, Financial).
Wall Street Analysts Forecast
Based on the one-year price targets offered by 19 analysts, the average target price for BioNTech SE (BNTX, Financial) is $137.12 with a high estimate of $173.27 and a low estimate of $111.46. The average target implies an upside of 38.37% from the current price of $99.09. More detailed estimate data can be found on the BioNTech SE (BNTX) Forecast page.
Based on the consensus recommendation from 21 brokerage firms, BioNTech SE's (BNTX, Financial) average brokerage recommendation is currently 2.0, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for BioNTech SE (BNTX, Financial) in one year is $31.89, suggesting a downside of 67.82% from the current price of $99.09. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the BioNTech SE (BNTX) Summary page.
